周一盘前，Structure Therapeutics Inc（股票代码：GPCR）股价大幅上涨9.50%，引发市场关注。
消息面上，知名投资银行HC Wainwright & Co.发布最新研究报告，维持对Structure Therapeutics的"买入"评级。尽管分析师将目标价从80.00美元小幅下调至75.00美元，但仍然保持看好态度。
分析认为，尽管目标价略有下调，但HC Wainwright & Co.维持"买入"评级显示了对公司基本面的持续信心。这一积极信号可能是推动Structure Therapeutics股价在盘前大幅上涨的主要原因。投资者似乎对公司的长期发展前景保持乐观，并认为当前股价可能低估了公司的潜在价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.